Statistics
Publications
9
Citations
329
H-Index
9
Active since
2018
Xiujuan Xiang is an author at Chinese Academy of Sciences specializing in nanomedicine, nanoparticle design, and pharmacology.
Publications per year
2018–2024
9
9
Hypoxia-Activated PEGylated Paclitaxel Prodrug Nanoparticles for Potentiated Chemotherapy
Dengyuan Hao, Qian Meng, Bowen Jiang et al. · ACS Nano · 2022 · 85 citations
Indocyanine green potentiated paclitaxel nanoprodrugs for imaging and chemotherapy
Xiujuan Xiang, Xuan Feng, Shaojin Lu et al. · Exploration · 2022 · 82 citations · Full text
Medicine, Oncology, Pharmacology +17
A Paclitaxel Prodrug with Copper Depletion for Combined Therapy toward Triple-Negative Breast Cancer
Dengyuan Hao, Qian Meng, Chaonan Li et al. · ACS Nano · 2023 · 47 citations
Pharmacy, Oncology, Pharmacology +17
Paclitaxel Prodrug Enables Glutathione Depletion to Boost Cancer Treatment
Biyou Zhang, Shiyu Zhou, Shaojin Lu et al. · ACS Nano · 2024 · 28 citations
Carboxylated paclitaxel prodrug nanofibers for enhanced chemotherapy
Shaojin Lu, Dengyuan Hao, Xiujuan Xiang et al. · Journal of Controlled Release · 2023 · 24 citations
1–5 of 9